• Optimizing Protocol Design and Enhancing Patient Enrollment

    Case Studies
    Oct. 30, 2018

    An emerging biopharmaceutical company was considering development of a pharmacologic agent for treatment of patients with diabetic kidney disease (DKD).

    An emerging biopharmaceutical company was considering development of a pharmacologic agent for treatment of patients with diabetic kidney disease (DKD).